Retevmo®

Description

Retevmo® (selpercatinib)

Retevmo® is a precision-targeted cancer therapy designed to treat cancers driven by abnormal RET gene alterations.

As a highly selective RET kinase inhibitor, Retevmo works by blocking the signals that help RET-altered cancer cells grow and spread. It is used in certain advanced lung cancers, thyroid cancers, and other RET fusion-positive solid tumors. (Retevmo)

Key Benefits

• Targets cancers with RET gene mutations or RET fusions
• Helps slow or stop tumor growth and progression
• Used in selected cases of:
  • Non-small cell lung cancer (NSCLC)
  • Medullary thyroid cancer (MTC)
  • RET fusion-positive thyroid cancer
  • Other advanced RET fusion-positive solid tumors
• Convenient oral capsule or tablet formulation
• Precision oncology approach designed for molecularly targeted treatment (Retevmo)

How It Works

Retevmo contains selpercatinib, a selective RET kinase inhibitor that blocks abnormal RET signaling pathways involved in cancer cell survival and growth. By targeting RET-driven tumors directly, it helps reduce cancer progression while minimizing effects on non-target cells. (Drugs.com)

Indications

Retevmo is approved for:

• RET fusion-positive non-small cell lung cancer (NSCLC)
• RET-mutant medullary thyroid cancer
• RET fusion-positive thyroid cancer
• Certain advanced RET fusion-positive solid tumors (Retevmo)

Administration

• Taken orally, usually twice daily
• Available in capsule and tablet forms
• Prescribed and monitored by an oncology specialist (Drugs.com)

Why Choose Retevmo

Retevmo represents a modern precision medicine approach, helping patients with RET-driven cancers receive treatment tailored to the genetic profile of their tumor. It offers targeted therapy options for patients who may benefit from biomarker-driven cancer treatment. (Retevmo)

Important Safety Information

Common side effects may include:

• High blood pressure
• Fatigue
• Dry mouth
• Diarrhea
• Elevated liver enzymes

Serious risks may include liver toxicity, lung inflammation, heart rhythm problems, and allergic reactions. Treatment requires ongoing medical monitoring. (Drugs.com)